Synonyms: Neumega®
oprelvekin is an approved drug (FDA (1997))
Compound class:
Peptide
Comment: This is a non-glycosylated, recombinant form of human IL-11 produced in E.coli. Oprelvekin is one amino acid shorter than the endogenous peptide, lacking the amino-terminal proline residue.
|
Classification ![]() |
|
Compound class | Peptide |
Approved drug? | Yes. FDA (1997) |
International Nonproprietary Names ![]() |
|
INN number | INN |
7558 | oprelvekin |
Synonyms ![]() |
Neumega® |
Database Links ![]() |
|
ChEMBL Ligand | CHEMBL1201573 |
DrugBank Ligand | DB00038 |
GtoPdb PubChem SID | 178103550 |
Search PubMed clinical trials | oprelvekin |
Search PubMed titles | oprelvekin |
Search PubMed titles/abstracts | oprelvekin |
Wikipedia | Oprelvekin |